Your search matched 1 results
COVID-19 Kicks Drug Pricing Down the Road | In The Media
Meg Alexander, head of the reputation and risk management practice at Syneos Health, and Jeff Stewart, managing director at Syneos Health Consulting, teamed up with MM&M to discuss implications of COVID-19 and the upcoming US election on drug pricing.
Already have a RSS feed reader?